<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Vyhnankova S</submitter><funding>Ministry of Health of the Czech Republic - AZV CR</funding><funding>European Union - Next Generation EU</funding><funding>Charles University project COOPERATIO-Onco</funding><pagination>8844</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12469655</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>26(18)</volume><pubmed_abstract>Head and neck squamous cell carcinomas (HNSCCs) represent a diverse group of malignancies, both clinically and biologically, with human papillomavirus (HPV) infection playing a significant role. HPV-positive tumours generally tend to have a better prognosis and are driven by oncoproteins E6 and E7. In contrast, HPV-negative tumours typically have a worse prognosis and are often linked to mutations in tumour suppressor genes. HNSCCs exist within a complex environment known as the tumour microenvironment (TME). The TME includes tumour cells, cancer stem cells (CSCs), cancer-associated fibroblasts (CAFs), immune cells, extracellular matrix (ECM), blood vessels, and various signalling molecules. These components support tumour progression, invasion, metastasis, and resistance to treatment. Intercellular signalling within the TME-mediated by cytokines such as IL-6, TGF-b, and galectins-further promotes tumour growth and systemic effects like cachexia. Notably, the TME shares features with granulation tissue during wound healing, supporting the concept of cancer as a chronic, non-resolving wound. Effective therapy must target not only tumour cells but also the dynamic TME.</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>Cold, Hot, and Lethal-The Tumour Microenvironment and the Immunology of Head and Neck Squamous Cell Carcinoma.</pubmed_title><pmcid>PMC12469655</pmcid><funding_grant_id>NW24-03-00459</funding_grant_id><funding_grant_id>COOPERATIO-Onco</funding_grant_id><funding_grant_id>Programme EXCELES, ID Project No. LX22NPO5102</funding_grant_id><pubmed_authors>Plzak J</pubmed_authors><pubmed_authors>Vyhnankova S</pubmed_authors><pubmed_authors>Sindelka R</pubmed_authors><pubmed_authors>Smetana K</pubmed_authors><pubmed_authors>Netusil J</pubmed_authors><pubmed_authors>Lacina L</pubmed_authors><pubmed_authors>Kolar M</pubmed_authors><pubmed_authors>Chovanec M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Cold, Hot, and Lethal-The Tumour Microenvironment and the Immunology of Head and Neck Squamous Cell Carcinoma.</name><description>Head and neck squamous cell carcinomas (HNSCCs) represent a diverse group of malignancies, both clinically and biologically, with human papillomavirus (HPV) infection playing a significant role. HPV-positive tumours generally tend to have a better prognosis and are driven by oncoproteins E6 and E7. In contrast, HPV-negative tumours typically have a worse prognosis and are often linked to mutations in tumour suppressor genes. HNSCCs exist within a complex environment known as the tumour microenvironment (TME). The TME includes tumour cells, cancer stem cells (CSCs), cancer-associated fibroblasts (CAFs), immune cells, extracellular matrix (ECM), blood vessels, and various signalling molecules. These components support tumour progression, invasion, metastasis, and resistance to treatment. Intercellular signalling within the TME-mediated by cytokines such as IL-6, TGF-b, and galectins-further promotes tumour growth and systemic effects like cachexia. Notably, the TME shares features with granulation tissue during wound healing, supporting the concept of cancer as a chronic, non-resolving wound. Effective therapy must target not only tumour cells but also the dynamic TME.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-05-01T03:22:34.702Z</modification><creation>2026-05-01T03:11:20.518Z</creation></dates><accession>S-EPMC12469655</accession><cross_references><pubmed>41009413</pubmed><doi>10.3390/ijms26188844</doi></cross_references></HashMap>